Skip to main content

BIOHARVEST SCIENCES INC.

جودة البيانات: 83%
BHST
NASDAQ Manufacturing Chemicals
KWD 4.30
▲ KWD 0.03 (0.70%)
6 months return
Momentum
Neutral
ROE
-83.17%

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)37.00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-83.17%
أقل من متوسط القطاع (-54.47%)
ROICN/A
Net Margin-32.27%
Op. Margin-16.16%

الأمان

Debt / Equity
0.01
أقل من متوسط القطاع (0.30)
Current Ratio3.97
Interest CoverageN/A

التقييم

PE (TTM|NTM)
-8.79 | -107.75
أقل من متوسط القطاع (-1.50)
P/B Ratio3.85
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Debt/Equity of 0.01 — conservative balance sheet
Negative free cash flow of -9.58 M
Capital efficient — spends only 6.82% of revenue on capex

Price History

الاتجاهات المالية

السعر المستهدف للمحللين

4 محللين
Buy
+196.5%
upside to target
الحالي
KWD 4.30
Consensus Target
KWD 12.75
KWD 10.00
أدنى
KWD 15.00
أعلى
التوقعات
مكرر الربحية المستقبلي
-107.75
ربحية السهم المستقبلية
-KWD 0.04
الإيرادات المقدّرة
61.15 M

مفاجآت الأرباح

EPS
Reported Estimate Forecast
Next: Q1 2026 · EPS Est: -KWD 0.12 · Rev Est: 8.52 M
Q12025 Q22025 Q32025 Q42025 Q1 '26 Q2 '26
Reported -KWD 0.13 -KWD 0.24 -KWD 0.14 -KWD 0.10
Estimate -KWD 0.12 -KWD 0.11 -KWD 0.12 -KWD 0.11 -KWD 0.12 -KWD 0.10
المفاجأة -8.33% -123.26% -21.74% +4.76%

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) 37.00% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: -83.17% · Net Margin: -32.27%
Revenue (TTM) 34.51 M Net Income (TTM) -11.14 M
ROE -83.17% ROA N/A
Gross Margin N/A Operating Margin -16.16%
Net Margin -32.27% Free Cash Flow (TTM) -9.58 M
ROIC N/A FCF Growth (3Y) N/A

Safety

D/E: 0.01 · Current: 3.97
Debt / Equity 0.01 Current Ratio 3.97
Interest Coverage N/A Asset Turnover N/A
Working Capital 22.82 M Tangible Book Value 25.45 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -8.79 · EV/EBITDA: N/A
P/E Ratio -8.79 Forward P/E -107.75
P/B Ratio 3.85 P/S Ratio 2.84
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 1.60 Fwd Earnings Yield N/A
FCF Yield -9.78%
Market Cap 97.93 M Enterprise Value 75.05 M

Per Share

EPS: N/A · FCF/Share: -0.42
EPS (Diluted TTM) N/A Revenue / Share 1.52
FCF / Share -0.42 OCF / Share -0.32
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 86.04% · CapEx/Rev: 6.82%
CapEx / Revenue 6.82% FCF Conversion 86.04%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024
Revenue 34.51 M 25.19 M
Net Income -11.14 M -12.91 M
EPS (Diluted)
Gross Profit
Operating Income -5.58 M -6.99 M
EBITDA
R&D Expenses
SG&A Expenses
D&A 1.62 M 1.25 M
Interest Expense
Income Tax -76,000.0 8,000.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024
Total Assets
Total Liabilities
Shareholders' Equity 25.45 M 1.33 M
Total Debt 149,000.0 3.91 M
Cash & Equivalents 23.03 M 2.39 M
Current Assets 30.50 M 7.86 M
Current Liabilities 7.68 M 14.26 M

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1605 نظير)
المقياس السهم وسيط القطاع
P/E -8.8 -1.5
P/B 3.9 1.6
ROE % -83.2 -54.5
Net Margin % -32.3 -41.5
Rev Growth 5Y % 1.7
D/E 0.0 0.3